Abstract
Studies indicated that CC receptor 5 (CCR5), as a receptor for CC ligand 3, CCL4, and CCL5, plays important roles in the recruitment of T cytotoxic lymphocytes to the liver of chronic HBV (CHB)-infected patients. The main purpose of this study was to investigate the expression levels of CCR5 on the CD8+ T lymphocytes of CHB patients. This clinical study was performed on 63 CHB patients and 96 healthy controls. Flow cytometric analysis was performed to examine the expression of CCR5 on CD8+ T cells of CHB patients. Real-time PCR was also used for HBV-DNA quantification. The results of our study demonstrated that CCR5 expressing T cytotoxic cells were decreased significantly in CHB patients in comparison to healthy control. Based on our results, it can be concluded that the percent of CCR5+/CD8+ T cells in Iranian CHB patients is significantly decreased, hence their migration to the infected liver, and HBV eradication from the hepatocytes is disrupted.
Similar content being viewed by others
References
Assar S, Arababadi MK, Mohit M, et al. 2012 T helper and B cell escape mutations within the HBc gene in patients with asymptomatic HBV infection: A study from the south-eastern region of Iran. Clin Lab. Article in press.
Ahn, S.H., D.Y. Kim, H.Y. Chang, et al. 2006. Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea. Journal of Medical Virology 78: 1564–1571.
Herceg, Z., and A. Paliwal. 2011. Epigenetic mechanisms in hepatocellular carcinoma: Ow environmental factors influence the epigenome. Mutation Research 727: 55–61.
Arababadi, M.K., A.A. Pourfathollah, A. Jafarzadeh, et al. 2010. Decreased expression of CCR5 on the NK cells in occult HBV infected patients. Laboratory Medicine 41: 735–738.
Arababadi, M.K., A.A. Pourfathollah, A. Jafarzadeh, et al. 2010. Peripheral blood CD8+ T cells CCR5 expression and its ∆32 mutation in Iranian patients with occult hepatitis B infection. Laboratory Medicine 41: 226–230.
Crane, I.J., H. Xu, C. Wallace, et al. 2006. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis. Journal of Leukocyte Biology 79: 435–443.
Khan, I.A., S.Y. Thomas, M.M. Moretto, et al. 2006. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathogens 2: e49.
Ajuebor, M.N., J.A. Carey, and M.G. Swain. 2006. CCR5 in T cell-mediated liver diseases: What's going on? Journal of Immunology 177: 2039–2045.
Fisicaro, P., C. Valdatta, C. Boni, et al. 2009. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58: 974–982.
Rahbar, R., T.T. Murooka, and E.N. Fish. 2009. Role for CCR5 in dissemination of vaccinia virus in vivo. Journal of Virology 83: 2226–2236.
Liu, H.G., W.W. Chen, Z.P. Fan, et al. 2007. The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope. Clinical Immunology 125: 337–345.
Lee, C.K., J.H. Suh, Y.S. Cho, et al. 2002. Chemokine receptor expression of hepatitis B virus-specific CD8+ lymphocyte in chronic B viral infection. Taehan Kan Hakhoe Chi 8: 363–370.
Shimada, N., K. Yamamoto, M.J. Kuroda, et al. 2003. HBcAg-specific CD8 T cells play an important role in virus suppression, and acute flare-up is associated with the expansion of activated memory T cells. Journal of Clinical Immunology 23: 223–232.
TrehanPati, N., and R. Geffers. 2009. Sukriti, et al. Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection. Hepatology 49: 781–790.
Suneetha, P.V., S.K. Sarin, A. Goyal, et al. 2006. Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease. Journal of Hepatology 44: 856–863.
Chen, D.Q., Y. Zeng, J. Zhou, et al. 2010. Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population. Journal of Medical Virology 82: 371–378.
Chang, H.Y., S.H. Ahn, D.Y. Kim, et al. 2005. Association between CCR5 promoter polymorphisms and hepatitis B virus infection. The Korean Journal of Hepatology 11: 116–124.
Arababadi, M.K., G. Hassanshahi, H. Azin, et al. 2010. No association between CCR5-∆32 mutation and multiple sclerosis in patients of south-eastern of Iran. Laboratory Medicine 41: 31–33.
Arababadi, M.K., N. Naghavi, G. Hassanshahi, et al. 2009. Is CCR5-delta32 mutation associated with diabetic nephropathy in type 2 diabetes? Annals of Saudi Medicine 29: 413.
Acknowledgments
Authors of this article take this opportunity to thank all of the CHB patients and healthy controls who enrolled and contributed in this research. This project was supported by a grant from the Rafsanjan University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahmadabadi, B.N., Hassanshahi, G., Khoramdelazad, H. et al. Downregulation of CCR5 Expression on the Peripheral Blood CD8+ T Cells of Southeastern Iranian Patients with Chronic Hepatitis B Infection. Inflammation 36, 136–140 (2013). https://doi.org/10.1007/s10753-012-9528-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-012-9528-4